The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Managed Care Programs

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Managed Care Programs


Psychiatry related information on Managed Care Programs


High impact information on Managed Care Programs

  • We studied six large medical groups in California--Bristol Park Medical, Friendly Hills HealthCare Network, HealthCare Partners Medical Group, Mullikin Medical Centers, Palo Alto Medical Foundation, and San Jose Medical Group--that are paid through capitation and that are growing as a result of contracts with managed-care organizations [11].
  • DESIGN AND SETTING: Retrospective study of prescription claims from a managed care organization database for all patients with cisapride prescriptions between July 1993 and December 1998 [12].
  • The Supreme Court's view of the managed care industry's liability for adverse patient outcomes [13].
  • Managed care in JAMA and the Archives journals. A call for papers for coordinated theme issues [14].
  • SETTING: Large managed care organization [15].

Chemical compound and disease context of Managed Care Programs


Biological context of Managed Care Programs

  • This study investigates clinical practice outcomes and utilization efficiencies of collaborative Med/Peds family practice physicians within a community, which should provide an effective model in a growing managed care environment [21].
  • RESULTS: Care-managed patients achieved higher rates of use of angiotensin-converting enzyme inhibitor than baseline or non-care-managed patients (95%, 60%, and 75%, respectively; P<.001), as well as increased adherence to guidelines for daily weight monitoring and assessment of left ventricular function [22].
  • Nuclear medicine physician workforce requirements, Part 2: Benchmarking U.S. nuclear medicine physician workforce requirements based on managed care organization effects. Special Committee on Manpower [23].
  • The risk of a referral being made for discretionary reasons was increased by capitated primary care payment, internal medicine specialty of the PCP, high concentration of specialists in the community, and higher levels of managed care in the practice [24].
  • Correlates of knowledge of one's blood pressure and cholesterol levels among older members of a managed care plan [25].

Anatomical context of Managed Care Programs

  • DESIGN: This study was conducted in a managed care organization to determine the extent of the use of unopposed estrogen in women with intact uteri [26].
  • PURPOSE: The statin-prescribing patterns in a large managed care organization and the effectiveness of statin prescriptions in lowering low-density-lipoprotein (LDL) cholesterol levels in patients with coronary artery disease (CAD) or risk-equivalent patients were examined [27].

Associations of Managed Care Programs with chemical compounds


Gene context of Managed Care Programs

  • Etanercept patients were younger than infliximab patients (mean [SD] age, 70.5 [4.6] vs 71.8 [4.6] years; P = 0.04), were less likely to be enrolled in a managed care organization (76.7% vs 87.8%; P < 0.01), and had fewer pretreatment rheumatologist visits (mean [SD], 1.3 [2.3] vs 2.2 [3.8]; P = 0.04) [32].
  • Coverage inequalities of new therapies for rheumatoid arthritis in a managed care setting [33].
  • OBJECTIVE: To describe the impact on patients and physicians at a managed care organization (MCO) of a direct-to-consumer advertising (DTC-ad) campaign concerning testing for the BRCA1 and BRCA2 genes [34].
  • This article describes the posttreatment use of colon examinations, carcinoembryonic antigen (CEA) testing, and metastatic disease testing among a managed care population [35].
  • The evolution of formal criteria for patient placement such as the ASAM criteria is a beneficial, adaptive process that is underway in numerous states, managed care entities, professional provider societies, and provider groups [36].

Analytical, diagnostic and therapeutic context of Managed Care Programs


  1. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Lanes, S.F., Lanza, L.L., Radensky, P.W., Yood, R.A., Meenan, R.F., Walker, A.M., Dreyer, N.A. Arthritis Rheum. (1997) [Pubmed]
  2. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective. Lofland, J.H., Johnson, N.E., Batenhorst, A.S., Nash, D.B. Arch. Intern. Med. (1999) [Pubmed]
  3. Federally funded sexually transmitted disease programs and managed care: a review of current and planned partnerships. Rein, D.B., Anderson, L.A., Gowda, V.R., Dixon, J., Irwin, K.L. Sexually transmitted diseases. (2001) [Pubmed]
  4. Decreased attendance at cystic fibrosis centers by children covered by managed care insurance. Nathanson, I., Ramírez-Garnica, G., Wiltrout, S.A. American journal of public health. (2005) [Pubmed]
  5. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Melikian, C., White, T.J., Vanderplas, A., Dezii, C.M., Chang, E. Clinical therapeutics. (2002) [Pubmed]
  6. Troponin T or troponin I or CK-MB (or none?). Collinson, P.O. Eur. Heart J. (1998) [Pubmed]
  7. A model for managed behavioral health care in an academic department of psychiatry. Fagan, P.J., Schmidt, C.W., Cook, B. Psychiatric services (Washington, D.C.) (2002) [Pubmed]
  8. A case-control study of erectile dysfunction among men diagnosed with panic disorder. Blumentals, W.A., Gomez-Caminero, A., Brown, R.R., Vannappagari, V., Russo, L.J. Int. J. Impot. Res. (2004) [Pubmed]
  9. Monitoring change in behavioral health care. The role of the Center for Mental Health Services. Teich, J.L. Psychiatr. Clin. North Am. (2000) [Pubmed]
  10. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder. Perwien, A., Hall, J., Swensen, A., Swindle, R. Journal of managed care pharmacy : JMCP. (2004) [Pubmed]
  11. The growth of medical groups paid through capitation in California. Robinson, J.C., Casalino, L.P. N. Engl. J. Med. (1995) [Pubmed]
  12. Coprescribing and codispensing of cisapride and contraindicated drugs. Jones, J.K., Fife, D., Curkendall, S., Goehring, E., Guo, J.J., Shannon, M. JAMA (2001) [Pubmed]
  13. The Supreme Court's view of the managed care industry's liability for adverse patient outcomes. Jacobson, P.D. JAMA (2000) [Pubmed]
  14. Managed care in JAMA and the Archives journals. A call for papers for coordinated theme issues. Lundberg, G.D. JAMA (1995) [Pubmed]
  15. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Nichol, K.L., Baken, L., Nelson, A. Ann. Intern. Med. (1999) [Pubmed]
  16. Cholesterol management in the era of managed care. Grundy, S.M. Am. J. Cardiol. (2000) [Pubmed]
  17. A pharmacoeconomic assessment of enoxaparin and warfarin as prophylaxis for deep vein thrombosis in patients undergoing knee replacement surgery. Hawkins, D.W., Langley, P.C., Krueger, K.P. Clinical therapeutics. (1998) [Pubmed]
  18. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Jacobson, G.F., Ramos, G.A., Ching, J.Y., Kirby, R.S., Ferrara, A., Field, D.R. Am. J. Obstet. Gynecol. (2005) [Pubmed]
  19. Managed care does not lower costs but may result in poorer outcomes for patients with gestational diabetes. Bienstock, J.L., Blakemore, K.J., Wang, E., Presser, D., Misra, D., Pressman, E.K. Am. J. Obstet. Gynecol. (1997) [Pubmed]
  20. Alternate financial incentives in multi-tiered formulary systems to improve accountability for outcomes. Chung, R.S., Taira, D.A., Noh, C. Journal of managed care pharmacy : JMCP. (2003) [Pubmed]
  21. A community collaborative practice experience between Med/Peds and family practice. Onady, G.M. Am. J. Med. (1997) [Pubmed]
  22. Impact of a guideline-based disease management team on outcomes of hospitalized patients with congestive heart failure. Costantini, O., Huck, K., Carlson, M.D., Boyd, K., Buchter, C.M., Raiz, P., Cooper, G.S. Arch. Intern. Med. (2001) [Pubmed]
  23. Nuclear medicine physician workforce requirements, Part 2: Benchmarking U.S. nuclear medicine physician workforce requirements based on managed care organization effects. Special Committee on Manpower. Clouse, J.C., Rogers, M., Reba, R.C., Littlefield, J.L., Schneider, P.B., Pollycove, M. J. Nucl. Med. (1998) [Pubmed]
  24. Primary care physician specialty referral decision making: patient, physician, and health care system determinants. Forrest, C.B., Nutting, P.A., von Schrader, S., Rohde, C., Starfield, B. Medical decision making : an international journal of the Society for Medical Decision Making. (2006) [Pubmed]
  25. Correlates of knowledge of one's blood pressure and cholesterol levels among older members of a managed care plan. Harawa, N.T., Morgenstern, H., Beck, J., Moore, A. Aging (Milan, Italy) (2001) [Pubmed]
  26. Use of unopposed estrogen in women with uteri: prevalence, clinical implications, and economic consequence. White, V.E., Bennett, L., Raffin, S., Emmett, K., Coleman, M.J. Menopause (New York, N.Y.) (2000) [Pubmed]
  27. Dyslipidemia treatment among patients with coronary artery disease in a managed care organization. Lewis, B.E., McDonough, K. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. (2004) [Pubmed]
  28. Lithium use and discontinuation in a health maintenance organization. Johnson, R.E., McFarland, B.H. The American journal of psychiatry. (1996) [Pubmed]
  29. Improving efficacy of diabetes management using treatment algorithms in a mainly Hispanic population. Fanning, E.L., Selwyn, B.J., Larme, A.C., DeFronzo, R.A. Diabetes Care (2004) [Pubmed]
  30. Diabetes reporting as a cause of death: results from the Translating Research Into Action for Diabetes (TRIAD) study. McEwen, L.N., Kim, C., Haan, M., Ghosh, D., Lantz, P.M., Mangione, C.M., Safford, M.M., Marrero, D., Thompson, T.J., Herman, W.H. Diabetes Care (2006) [Pubmed]
  31. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Karter, A.J., Ferrara, A., Darbinian, J.A., Ackerson, L.M., Selby, J.V. Diabetes Care (2000) [Pubmed]
  32. Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged > or =65 years with rheumatoid arthritis. Weycker, D., Yu, E.B., Woolley, J.M., Oster, G. Clinical therapeutics. (2005) [Pubmed]
  33. Coverage inequalities of new therapies for rheumatoid arthritis in a managed care setting. Gallup, E. Managed care interface. (2001) [Pubmed]
  34. Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: reactions from women and their physicians in a managed care organization. Mouchawar, J., Laurion, S., Ritzwoller, D.P., Ellis, J., Kulchak-Rahm, A., Hensley-Alford, S. The American journal of managed care. (2005) [Pubmed]
  35. Sociodemographic differences in the receipt of colorectal cancer surveillance care following treatment with curative intent. Elston Lafata, J., Cole Johnson, C., Ben-Menachem, T., Morlock, R.J. Medical care. (2001) [Pubmed]
  36. Treatment matching. Theoretic basis and practical implications. Gastfriend, D.R., McLellan, A.T. Med. Clin. North Am. (1997) [Pubmed]
  37. Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study. Brown, A.F., Gregg, E.W., Stevens, M.R., Karter, A.J., Weinberger, M., Safford, M.M., Gary, T.L., Caputo, D.A., Waitzfelder, B., Kim, C., Beckles, G.L. Diabetes Care (2005) [Pubmed]
  38. Managed care organization and the quality of diabetes care: the Translating Research Into Action for Diabetes (TRIAD) study. Kim, C., Williamson, D.F., Mangione, C.M., Safford, M.M., Selby, J.V., Marrero, D.G., Curb, J.D., Thompson, T.J., Narayan, K.M., Herman, W.H. Diabetes Care (2004) [Pubmed]
  39. Alarums false, alarums real: challenges and threats to the future of epidemiology. Bracken, M.B. Annals of epidemiology. (1998) [Pubmed]
  40. Downward trends in bronchoscopies performed between 1991 and 1997. Balfe, D., Mohsenifar, Z. Chest (1999) [Pubmed]
WikiGenes - Universities